Cargando…
Dosing of zoledronic acid with its anti-tumor effects in breast cancer
Bisphosphonates have played an important role in the treatment of breast cancer, mainly in patients with bone metastasis, by reducing the risk of fracture, spinal cord compression, and hypercalcemia. Zoledronic acid, the most frequently used intravenous agent, has been traditionally administered on...
Autores principales: | Zhao, Xinmin, Hu, Xichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648996/ https://www.ncbi.nlm.nih.gov/pubmed/26587376 http://dx.doi.org/10.1016/j.jbo.2015.08.001 |
Ejemplares similares
-
Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid
por: Zhao, Xinmin, et al.
Publicado: (2011) -
The anti-tumour effects of zoledronic acid
por: Zekri, Jamal, et al.
Publicado: (2014) -
Anti-Tumor Effects of Low Dose Zoledronate on Lung Cancer-Induced Spine Metastasis
por: Akoury, Elie, et al.
Publicado: (2019) -
The evolving role of zoledronic acid in early breast cancer
por: Gnant, Michael
Publicado: (2009) -
Human stromal cells are required for an anti-breast cancer effect of zoledronic acid
por: Nienhuis, Hilde H., et al.
Publicado: (2015)